ticlopidine has been researched along with Ventricular Dysfunction, Left in 15 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the current era of early revascularization and routine use of dual antiplatelet therapy, the incremental benefit of warfarin to reduce the incidence of left ventricular thrombus (LVT) in patients with impaired left ventricular ejection fraction post anterior ST-elevation myocardial infarction (aSTEMI), remains uncertain." | 9.14 | Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial. ( Ahmad, M; Eikelboom, JW; Natarajan, MK; Salehian, O; Schwalm, JD, 2010) |
| "Participants in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE) trials with HF, but not randomized to oral anticoagulation, were categorized as having preserved versus reduced ejection fraction." | 5.20 | Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. ( Connolly, SJ; Hart, RG; Healey, JS; Hohnloser, SH; McAlister, FA; Pfeffer, MA; Sandhu, RK; Yuan, F; Yusuf, S, 2015) |
| "In the current era of early revascularization and routine use of dual antiplatelet therapy, the incremental benefit of warfarin to reduce the incidence of left ventricular thrombus (LVT) in patients with impaired left ventricular ejection fraction post anterior ST-elevation myocardial infarction (aSTEMI), remains uncertain." | 5.14 | Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial. ( Ahmad, M; Eikelboom, JW; Natarajan, MK; Salehian, O; Schwalm, JD, 2010) |
| "Chronic myocardial ischemia was induced using a minimally invasive model in 16 landrace pigs." | 1.37 | Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure. ( Abegunewardene, N; Gori, T; Horstick, G; Kreitner, KF; Lehr, HA; Münzel, T; Schmidt, KH; Schreiber, LM; Vosseler, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lanzillo, C | 1 |
| Di Roma, M | 1 |
| Sciahbasi, A | 1 |
| Minati, M | 1 |
| Maresca, L | 1 |
| Pendenza, G | 1 |
| Romagnoli, E | 1 |
| Summaria, F | 1 |
| Patrizi, R | 1 |
| Di Luozzo, M | 1 |
| Preziosi, P | 1 |
| Lioy, E | 1 |
| Romeo, F | 1 |
| Blancas Gómez-Casero, R | 1 |
| Quintana Díaz, M | 1 |
| Chana García, M | 1 |
| Martín Parra, C | 1 |
| López Matamala, B | 1 |
| Estébanez Montiel, B | 1 |
| Ballesteros Ortega, D | 1 |
| Martínez González, O | 1 |
| Vigil Escribano, D | 1 |
| Prieto Valderrey, F | 1 |
| Marina Martínez, L | 1 |
| Castro Gallego, O | 1 |
| Motovska, Z | 1 |
| Ondrakova, M | 1 |
| Doktorova, M | 1 |
| Widimsky, P | 1 |
| Sandhu, RK | 1 |
| Hohnloser, SH | 1 |
| Pfeffer, MA | 1 |
| Yuan, F | 1 |
| Hart, RG | 1 |
| Yusuf, S | 1 |
| Connolly, SJ | 1 |
| McAlister, FA | 1 |
| Healey, JS | 1 |
| Nakashima, K | 1 |
| Kirsch, ME | 1 |
| Vermes, E | 1 |
| Rosanval, O | 1 |
| Loisance, D | 1 |
| Schwalm, JD | 1 |
| Ahmad, M | 1 |
| Salehian, O | 1 |
| Eikelboom, JW | 1 |
| Natarajan, MK | 1 |
| Lemesle, G | 1 |
| Delhaye, C | 1 |
| Abegunewardene, N | 1 |
| Schmidt, KH | 1 |
| Vosseler, M | 1 |
| Kreitner, KF | 1 |
| Schreiber, LM | 1 |
| Lehr, HA | 1 |
| Gori, T | 1 |
| Münzel, T | 1 |
| Horstick, G | 1 |
| El-Menyar, A | 1 |
| AlHabib, KF | 1 |
| Al-Motarreb, A | 1 |
| Hersi, A | 1 |
| Al Faleh, H | 1 |
| Asaad, N | 1 |
| Al Saif, S | 1 |
| Almahmeed, W | 1 |
| Sulaiman, K | 1 |
| Amin, H | 1 |
| Al-Lawati, J | 1 |
| Alsheikh-Ali, AA | 1 |
| AlQahtani, A | 1 |
| Al-Sagheer, NQ | 1 |
| Singh, R | 1 |
| Al Suwaidi, J | 1 |
| Swiatkiewicz, I | 1 |
| Kozinski, M | 1 |
| Magielski, P | 1 |
| Gierach, J | 1 |
| Fabiszak, T | 1 |
| Kubica, A | 1 |
| Sukiennik, A | 1 |
| Navarese, EP | 1 |
| Odrowaz-Sypniewska, G | 1 |
| Kubica, J | 1 |
| Davutoglu, V | 1 |
| Soydinc, S | 1 |
| Sezen, Y | 1 |
| Wienbergen, H | 1 |
| Gitt, AK | 1 |
| Schiele, R | 1 |
| Juenger, C | 1 |
| Heer, T | 1 |
| Vogel, C | 1 |
| Gottwik, M | 1 |
| Senges, J | 1 |
| Goldberg, SL | 1 |
| Kuchulakanti, P | 1 |
| Kapetanakis, EI | 1 |
| Lew, R | 1 |
| Rha, SW | 1 |
| Cheneau, E | 1 |
| Satler, LF | 1 |
| Suddath, WO | 1 |
| Pichard, AD | 1 |
| Kent, KM | 1 |
| Pakala, R | 1 |
| Haile, E | 1 |
| Corso, P | 1 |
| Waksman, R | 1 |
| Horwich, TB | 1 |
| Fonarow, GC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry[NCT02264912] | 2,016 participants (Actual) | Observational [Patient Registry] | 2008-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ticlopidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
[Decreasing incidence of stent thrombosis].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Drug Therap | 2011 |
Prevention of heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Ant | 2002 |
2 trials available for ticlopidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopid | 2015 |
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Embolism; Feasibility Studies | 2010 |
11 other studies available for ticlopidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Echocardiogra | 2013 |
[Influence of the combination of antiplatelet agents on the occurrence of early left ventricular insufficiency in patients with acute coronary syndromes without persistent ST-segment elevation].
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; F | 2014 |
Severe left ventricular systolic dysfunction is independently associated with high on-clopidogrel platelet reactivity.
Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Female; Humans | 2014 |
Off-pump replacement of the INCOR implantable axial-flow pump.
Topics: Anticoagulants; Aspirin; Clopidogrel; Equipment Design; Heart-Assist Devices; Humans; Infusion Pumps | 2009 |
Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure.
Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Contrast Media; Coronary Angiography; Coronary Stenos | 2011 |
Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug The | 2012 |
Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Biom | 2012 |
Complete lysis of left ventricular giant thrombus with fibrinolytic therapy in clopidogrel resistant patient.
Topics: Clopidogrel; Drug Resistance; Electrocardiography; Female; Humans; Middle Aged; Thrombolytic Therapy | 2003 |
Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry).
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converti | 2004 |
Why don't we practice evidence-based medicine?
Topics: Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Evidence-Based M | 2005 |
Impact of continued hospitalization in patients pre-treated with clopidogrel prior to coronary angiography and undergoing coronary artery bypass grafting.
Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Female; Ho | 2005 |